DSGN icon

Design Therapeutics
DSGN

Overview Fund Activity

88 hedge funds and large institutions have $85.5M invested in Design Therapeutics in 2023 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 14 closing their positions.

Holders
88
Holders Change
+1
Holders Change %
+1.15%
% of All Funds
1.29%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
15
Increased
36
Reduced
25
Closed
14
Calls
$253K
Puts
$335K
Net Calls
-$82K
Net Calls Change
-$46K

Top Buyers

1
BCM
1
BML Capital Management
Indiana
$2.73M
2
AC
2
Almitas Capital
California
$2.72M
3
Morgan Stanley
3
Morgan Stanley
New York
$2.88M
4
Goldman Sachs
4
Goldman Sachs
New York
$2.71M
5
Jacobs Levy Equity Management
5
Jacobs Levy Equity Management
New Jersey
$1.46M

Top Sellers

1
RI
1
RTW Investments
New York
$0
2
PM
2
Prosight Management
Texas
$742K
3
SCM
3
Soleus Capital Management
Connecticut
$0
4
Citadel Advisors
4
Citadel Advisors
Florida
$4.86M
5
Principal Financial Group
5
Principal Financial Group
Iowa
$40.3K
Name Market Value Shares Shares
Change 		Shares
Change %
Point72 Asset Management
101
Point72 Asset Management
Connecticut
– – -1 Closed
CFGS
102
Concourse Financial Group Securities
Alabama
– – – –
C
103
Covestor
United Kingdom
$0 34 +17 +100%
1 2 3 4
5